Wealthfront Advisers’s DexCom DXCM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $921K | Buy |
10,546
+1,022
| +11% | +$89.2K | ﹤0.01% | 695 |
|
2025
Q1 | $650K | Sell |
9,524
-17,309
| -65% | -$1.18M | ﹤0.01% | 738 |
|
2024
Q4 | $2.09M | Buy |
26,833
+6,555
| +32% | +$510K | 0.01% | 520 |
|
2024
Q3 | $1.36M | Sell |
20,278
-26,387
| -57% | -$1.77M | ﹤0.01% | 591 |
|
2024
Q2 | $5.29M | Buy |
46,665
+1,026
| +2% | +$116K | 0.02% | 259 |
|
2024
Q1 | $6.33M | Sell |
45,639
-825
| -2% | -$114K | 0.02% | 219 |
|
2023
Q4 | $5.77M | Buy |
46,464
+602
| +1% | +$74.7K | 0.02% | 215 |
|
2023
Q3 | $4.28M | Buy |
45,862
+2,673
| +6% | +$249K | 0.02% | 241 |
|
2023
Q2 | $5.55M | Buy |
43,189
+8,875
| +26% | +$1.14M | 0.02% | 196 |
|
2023
Q1 | $3.99M | Sell |
34,314
-657
| -2% | -$76.3K | 0.02% | 248 |
|
2022
Q4 | $3.96M | Buy |
34,971
+2,673
| +8% | +$303K | 0.02% | 245 |
|
2022
Q3 | $2.6M | Buy |
32,298
+5,616
| +21% | +$452K | 0.01% | 312 |
|
2022
Q2 | $1.99M | Buy |
26,682
+23,841
| +839% | +$1.78M | 0.01% | 387 |
|
2022
Q1 | $1.45M | Sell |
2,841
-908
| -24% | -$465K | 0.01% | 462 |
|
2021
Q4 | $2.01M | Buy |
3,749
+2,344
| +167% | +$1.26M | 0.01% | 387 |
|
2021
Q3 | $768K | Buy |
1,405
+812
| +137% | +$444K | ﹤0.01% | 506 |
|
2021
Q2 | $253K | Sell |
593
-105
| -15% | -$44.8K | ﹤0.01% | 591 |
|
2021
Q1 | $251K | Sell |
698
-1,640
| -70% | -$590K | ﹤0.01% | 520 |
|
2020
Q4 | $864K | Buy |
2,338
+235
| +11% | +$86.8K | 0.01% | 378 |
|
2020
Q3 | $867K | Buy |
2,103
+238
| +13% | +$98.1K | 0.01% | 351 |
|
2020
Q2 | $756K | Buy |
+1,865
| New | +$756K | 0.01% | 367 |
|